REGNStock and Options Trade Setup — Regeneron Pharmaceuticals, Inc.
Nasdaq 100 · Healthcare (Biopharmaceuticals) · High-liquidity options · Large cap · ~$110B
Regeneron offers a high-quality franchise mix anchored by Dupixent (the multi-indication biologic blockbuster co-developed with Sanofi) which compounds in the high-teens annually as new indication approvals (eosinophilic esophagitis, COPD, chronic urticaria) expand the addressable market. The EYLEA franchise has faced biosimilar competition pressure but the higher-dose Eylea HD launch is preserving share at premium pricing. Libtayo provides immuno-oncology growth optionality. The pipeline includes promising assets in oncology (linvoseltamab, odronextamab) and obesity (trevogrumab + semaglutide combination). Strong free cash flow generation funds disciplined capital return and selective M&A. Operating margins are exceptional at 30%+ across cycles. Risk profile is moderate. Options are highly liquid with elevated IVR; both short-dated and earnings-driven setups have been productive given the news flow density around late-stage trial readouts.
Score History & Signal Changelog
Preview dataThis page is updated every 72 hours with the latest Scan results. Each data point below represents one complete algorithmic snapshot in time.
Signal Breakdown
Today's Trade Card
Options Profile
Risks & Fundamentals
Every setup carries risk. Here's what could move REGN against you, plus the key stats that frame any position.
- 1.EYLEA biosimilar erosion accelerating faster than Eylea HD switching
- 2.Dupixent trajectory decelerating as growth indications mature
- 3.Pipeline trial setbacks in oncology or obesity programmes
REGN Options Setup — Frequently Asked Questions
Is REGN a good options trade today?+
Regeneron Pharmaceuticals, Inc. (REGN) currently has an Amora Edge Score of 71/100, ranking it top 18% of today's scan. This composite score is built from four sub-signals — EMA cross, RSI zone, relative strength vs SPY, and volume surge — each scored 0–25. The current read is a bullish setup, so the algorithm is positioned bullish (calls / call debit spreads). A score above 65 typically warrants a trade card with stop and target; below that, the setup is on the watchlist but not actionable.
What is REGN's win rate on Stoptions.ai setups?+
REGN's historical win rate on closed Stoptions setups is 66%. Win rate is calculated as the percentage of past REGN trade cards that hit their target price before stopping out. Win rate is most meaningful once a ticker has 10+ closed trades — individual ticker rates can be noisy at smaller samples. Our portfolio-wide win rate across all closed trades is the more stable benchmark.
What strike and expiry does Stoptions.ai suggest for REGN?+
The strike and expiry are shown on the trade card at the top of this page when the setup is active. Stoptions.ai algorithmically selects strikes targeting delta 0.35–0.45 and expirations 30–45 days out, adjusted for current implied volatility rank (IVR). When IVR is high, the system favors call debit spreads to limit vega risk; when IVR is low, single-leg long calls are preferred. The card includes the contract symbol, mid-price entry, stop, and target.
How often is the REGN setup updated?+
Every 72 hours we refresh REGN's Amora Edge Score and trade card. The underlying scan runs daily at 9:00 AM ET (pre-market) and 9:30 AM ET (post-open), so any new signal change is reflected within one trading session. If REGN drops below the entry threshold or the regime shifts (e.g., SPY enters a confirmed bear), the trade card is replaced with a "no setup" notice automatically.
What does the Amora Edge Score measure for REGN?+
The Amora Edge Score is a 0–100 composite of four technical sub-signals applied to REGN: (1) EMA cross — is the 20-day above the 50-day with both trending up? (2) RSI zone — is momentum in the 50–70 sweet spot, or extended/weak? (3) Relative strength vs SPY — is REGN outperforming the market over 20 sessions? (4) Volume surge — is participation above the 20-day average? Each sub-signal contributes 0–25 points. REGN currently scores 71.
How does REGN compare to other Healthcare (Biopharmaceuticals) setups?+
REGN's sector rank and percentile against other Healthcare (Biopharmaceuticals) tickers we track is shown on the /tickers index — sortable by Amora Edge Score, win rate, or sector. For direct comparison, see the "Related Healthcare (Biopharmaceuticals) Options Setups" panel above. When multiple tickers in the same sector are scoring 80+, the algorithm flags the cluster as a sector rotation signal and may upweight position sizing.
Educational content only — not personalized investment advice. Options carry substantial risk.
Get a Friday Recap Including Setups Like REGN.
Every Friday at 4:30 PM ET — Trade of the Week, Signal Movement, Sector Spotlight, Technical Analysis, and more. A 4-minute read. Free.
No spam. One email Friday afternoon. Unsubscribe in one click.